William Blair research analyst Matt Phipps was quoted in Barron’s following the announcement of a new Medicare drug pricing structure by the Biden administration.
Equity Research
Matt Phipps Reacts to Medicare Drug Pricing Announcement in Barron’s
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
The Metals Royalty Company Inc.: Initiation of Research Coverage
William Blair initiated research coverage of The Metals Royalty Company Inc. (TMCR $5.41). The Metals Royalty Company is focused on acquiring critical metals and energy royalty interests that support U.S. mineral security, with key royalties in the NORI and Mesabi projects.
-
Lyntris Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Lyntris Inc. (LYNX $12.39), a supplier of mission-critical radio frequency, sensor, and software technologies enabling connectivity across air and missile defense, maritime awareness, and space-based missions.
-